Figure S7 from Allysine-Targeted Molecular MRI Enables Early Prediction of Chemotherapy Response in Pancreatic Cancer

Figure S7. MnL3 molecular MRI of PANC1 tumor-bearing mice before administration of vehicle or FOLFIRINOX. After randomly assigning PANC1 mice to FOLFIRINOX or vehicle group, MnL3 molecular MRI (0.1 mmol/kg, i.v., 60 min p.i.) showed equivalent tumor enhancement before administration of vehicle or FOLFIRINOX. (n = 8 for each group, Student’s t-test, two-tailed, ns, not significant.).